President Donald Trump announced a plan on Sunday to cut prescription drug prices in the U.S., triggering sharp market fluctuations across Asian markets. His executive order, slated for […]
Wellgistics Revolutionizes Pharma Payments with $50M Investment for XRP Integration
Wellgistics Health has taken a groundbreaking step in the pharmaceutical industry by integrating XRP into its payment systems, empowering 6,000 U.S. pharmacies to leverage this blockchain technology. The […]
Wellgistics Integrates XRP for Faster Pharmaceutical Payments
Wellgistics, a U.S.-listed pharmaceutical firm, is pioneering the use of Ripple’s XRP cryptocurrency to streamline payments and reserves in healthcare. This strategic move marks a significant step forward […]
Wellgistics Uses XRP to Facilitate $50 Million Real-Time Pharma Payments
Pharmaceutical company Wellgistics has made a significant move in utilizing XRP for real-time payments, securing a $50 million funding deal. This decision aims to streamline payments and reduce […]
XRP Revolutionizes Pharma Payments: Speed, Transparency, and Cost Savings
A Florida-based pharmaceutical company, Wellgistics, is spearheading a significant shift in pharma payment processing by leveraging the XRP blockchain network. This move aims to drastically improve efficiency and […]
Eli Lilly’s Stock Slumps as Company Cuts Profit Outlook Despite Q1 Success
Despite exceeding Wall Street expectations in its first quarter, Eli Lilly’s (NYSE: LLY) stock experienced a significant decline after the company announced a reduced profit forecast. The pharmaceutical […]
Pfizer Posts Revenue Decline in Q1 2025, Highlights Strategic Focus
Pfizer’s Q1 2025 financial report reveals a revenue decrease of 8% compared to the previous year, attributed primarily to reduced Paxlovid sales. Despite this decline, the company reported […]
Merck Exceeds Expectations in Q1 2025, Projecting Strong Growth
Merck & Co., Inc. (MRK) has released its financial results for the first quarter of 2025, showcasing a slight decrease in total sales compared to the same period […]
Roche Invests $50 Billion in U.S. Amid Tariff Concerns
To counter escalating tariffs, pharmaceutical giant Roche is investing $50 billion in the United States over the next five years. The investment will support expanding R&D facilities and […]
Eli Lilly’s Weight-Loss Pill Drives Stock Up as New Data Shows Potential
Eli Lilly has taken a major step forward in the weight-loss medication market with promising data for its new drug, indicating it could rival Ozempic from Novo Nordisk. […]
Eli Lilly’s Stock Surges as New Weight-Loss Pill Shows Promising Results
Eli Lilly’s shares surged following the announcement of this innovative pill’s efficacy, signaling a potential revolution in the weight management sector. With plans to seek regulatory approval by […]
Abbott Labs Delivers Record Q1 Earnings: Growth Fueled by Diversification
Abbott Laboratories has exceeded expectations in its first quarter of 2025, reporting robust revenue and earnings per share (EPS) growth while reaffirming its full-year outlook. The company’s diversified […]
U.S. Launches Investigations into Pharmaceutical and Chip Imports, Potential for Tariffs
The United States is actively investigating pharmaceutical and semiconductor imports, a move that signals a significant shift in its trade policy approach. These probes aim to identify potential […]
U.S. Imposes Tariffs on Imported Pharmaceuticals
President Donald Trump declared that the U.S. government has successfully addressed inflation and witnessed a rise in stock market values. This move will see the imposition of tariffs […]
Pharmaceutical Companies Face New U.S. Tariffs Impact
Major pharmaceutical companies are bracing for a wave of new tariffs set to take effect next month, potentially altering pricing strategies and supply chains. These tariffs aim to […]